Phase I (or Phase II) Dose-Ranging Clinical Trials: Proposal of a Two-Stage Bayesian Design (Q4796210): Difference between revisions

@@ Property / MaRDI profile type @@
+MaRDI publication profile
@@ Property / MaRDI profile type: MaRDI publication profile / rank @@
+Normal rank
@@ Property / Wikidata QID @@
+Q44361082
@@ Property / Wikidata QID: Q44361082 / rank @@
+Normal rank
@@ Property / cites work @@
+Monitoring Accumulating Data in a Clinical Trial
@@ Property / cites work: Monitoring Accumulating Data in a Clinical Trial / rank @@
+Normal rank
@@ Property / cites work @@
+Miscellanea. A stopping rule for the continual reassessment method
+Normal rank
@@ Property / cites work @@
+Continual Reassessment Method: A Likelihood Approach
+Normal rank
@@ Property / cites work @@
+Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
+Normal rank
@@ Property / cites work @@
+Statistical Issues in Drug Development
@@ Property / cites work: Statistical Issues in Drug Development / rank @@
+Normal rank
@@ Property / cites work @@
+A Strategy for Dose-Finding and Safety Monitoring Based on Efficacy and Adverse Outcomes in Phase I/II Clinical Trials
+Normal rank
@@ Property / full work available at URL @@
+https://doi.org/10.1081/bip-120017728
+Normal rank
@@ Property / OpenAlex ID @@
+W2069317340
@@ Property / OpenAlex ID: W2069317340 / rank @@
+Normal rank